Combination treatment with ibrilatazar and chemotherapy has demonstrated “promising efficacy and safety” in patients with advanced squamous non-small cell lung cancer (NSCLC), according to researchers ...
New research suggests that, from 2011 to 2023, there was an increase in early adult mortality in the United States.
NSAID use is associated with an increased risk of death from RCC among women but not among men, researchers found.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback